LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $256,750 | -51.5% | 174,660 | +4.9% | 0.00% | – |
Q2 2023 | $529,343 | +34.7% | 166,460 | 0.0% | 0.00% | – |
Q1 2023 | $392,846 | -24.3% | 166,460 | +11.4% | 0.00% | – |
Q4 2022 | $518,626 | -52.7% | 149,460 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $1,096,000 | +12.5% | 149,460 | 0.0% | 0.00% | – |
Q2 2022 | $974,000 | +29.0% | 149,460 | 0.0% | 0.00% | – |
Q1 2022 | $755,000 | -53.5% | 149,460 | +49.5% | 0.00% | -100.0% |
Q2 2021 | $1,624,000 | – | 100,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |